End Tuberculosis Now Act of 2026

The End Tuberculosis Now Act of 2026 directs the U.S. government to increase foreign assistance aimed at diagnosing, treating, and preventing tuberculosis globally. This legislation establishes specific goals to reduce TB incidence and mortality rates by 2030, requiring the President to prioritize funding for high-risk populations, drug-resistant cases, and the development of new diagnostics and vaccines. The bill mandates extensive annual reporting to Congress on program progress, including data on patient outcomes, research investments, and coordination with international partners, while setting the program to expire in 2033 if these targets are met.